ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Associated factors for postoperative morbidity and mortality following surgery of obstructive colon tumors

[version 1; peer review: awaiting peer review]
PUBLISHED 05 Sep 2025
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS AWAITING PEER REVIEW

This article is included in the Oncology gateway.

Abstract

Background

Intestinal obstruction is a frequent complication. Colonic tumors are the leading cause of death in developed countries. Its treatment is controversial because of the plethora of available procedures. An adequate assessment of the patient’s status and the results of each procedure will help in the choice of therapeutic measures. We aimed to determine the factors associatedwith postoperative morbid mortality in the setting of obstructive colon tumors.

Methods

We retrospectively studied patients who underwent surgery for obstructive colon tumors between 2011 and 2023 years.

Results

During the study’s period, 62 cases were included in the study. Left localization was predominant (n=51, 82.3%). Diverting ostomy was the most proposed procedure (n=22; 35.5%), followed by segmental resection (n=15; 24.2%). Postoperative complications occurred in 37.5% with the majority being surgical (n=14, 22.6%). Seven deaths were numbered (11%). Neurological comorbidity (p=0.027, OR=55%), hemodynamic instability (p≤0.000, OR=63%), peritoneal carcinosis (p<0.000, OR=60%), and catecholamine usage peroperatively (p=0.007, OR=57%) were associated with postoperative mortality.

Conclusion

Considering these results, surgeons can adequately choose the surgical procedure for at-risk patients, resulting in a less troubled postoperative course.

Keywords

Colon, tumor, intestinal, obstruction, surgery

Background

Intestinal obstruction is the most frequent emergency during the course of colon cancer, occurring in 75% to 90% of cases.14 It worsens oncological prognosis, negatively impacts overall survival, and can be life-threatening. In fact, mortality doubles from 3.4% to 8.5% in the case of non-elective surgery,5 implying a hazard ratio of 2.251.6 This applies irrespective of the T or N stage of the disease, and several studies have shown that for the same stage of the disease, occlusion worsens prognosis and reduces overall and disease-free survival.7,8

Severe postoperative complications are more frequent in colon cancer surgery with occlusion, and this may be explained by the patient’s unfavorable preoperative conditions and by a doubling of the rate of specific complications, such as anastomotic fistula in the case of occlusion.1,9 Indeed, the occurrence of postoperative complications is responsible for the decline in overall survival and recurrence-free survival, as shown by a meta-analysis of randomized phase III trials involving 5,530 patients.10

Prevention and management of postoperative complications are essential to improve the outcome of occluded colon cancer, as the occurrence of postoperative complications increases mortality.11,12

Traditional predictive features have limitations in identifying at-risk patients sufficiently early to effectively intervene.

Our main objective was to determine factors associatedwith postoperative morbidity and mortality. By targeting these factors, we can reduce postoperative morbidity with the aim of reducing hospital stays, minimizing costs, allowing early initiation of adjuvant chemotherapy, and subsequently reducing mortality. Furthermore, we aimed to shed light on the current treatment landscape with different procedures and provide a comparative study of different surgical methods. In addition, we studied the restoration of bowel continuity after stoma creation to assess the encountered difficulties and challenges impeding this second procedure.

Methods

Design and setting of the study

This was a monocentric descriptive retrospective study of patients who underwent surgery for obstructive colonic cancer between January 2011 and December 2023, over 13 years, in the General Surgery B Department of Rabta Hospital, Tunis.

Study participants

Were included all patients who had undergone surgery for obstructive colonic cancer.

The diagnosis of tumoral colonic occlusion was established based on the occurrence of a tetrad of bowel obstruction13: abdominal pain, vomiting, cessation of bowel movements and gas, and abdominal meteorism, confirmed by the presence of hydroaeric-levels on abdominal X-ray and/or colonic distension upstream of a tumoral organic obstruction on abdominal CT scan.

Are not included:

  • Colonic occlusion by an extrinsic compression

  • Non-occlusive stenosing colonic tumors

  • Recurrent colonic tumors

  • Patients who had colonic desobstruction with a stent

We have excluded:

  • Medical records that could not be used due to poorly specified or missing data

  • Patients who died upon their admission in our department before undergoing any surgery

Collected variables

We compiled demographic, clinical, biological, radiological, endoscopic, and operative data for all patients.

Written consent was obtained from included patients to participate in our study.

Left colonic cancer was defined as any cancer between the left colonic angle and the rectosigmoid junction. The localization of other tumorswithin the colonic frame was labeled as a right colonic tumor.

The first surgical procedure was performed to treat the intestinal obstruction with possible tumor resection. This included either one- or two-stage procedure. The one-stage procedure consisted of segmental resection with anastomosis (SR) either in an emergent setting or after resolution by conservative measures (medical treatment), and total or subtotal colectomy (TC or STC) with digestive anastomosis (ileorectal anastomosis in case of total colectomy or ileo-sigmoidal anastomosis after subtotal colectomy) either in an emergent setting or after resolution by conservative measures (medical treatment). The two-stage procedures included diverting ostomy (DS), segmental resection followed by stoma creation (SR-DS), total or subtotal colectomy followed by stoma creation (STC-DS), and Hartmann’s procedure. The second surgical procedure was performed if tumor resection was not performed or complete digestive anastomosis was completed. It consists of Hartmann reversal, stoma takedown, and resection following DS.

Judging criteria

The primary outcome measures were postoperative morbidity- and mortality-associated factors. All the surgical procedures were performed. The secondary outcome measure was the aftermath of stoma creation.

Postoperative morbidity was defined as the occurrence of a complication during the hospital stay or within 30 days postoperatively and graded according to the Clavien-Dindo classification. Postoperative mortality was defined as death during hospital admission or within 30 days of admission.

Complications were classified as non specific or general (events related to merely having surgery, medical complications, and non specific surgical complications) or specific (events related to surgical procedures.14

The secondary outcome measure was restoring bowel continuity after stoma creationto assess the encountered difficulties and challenges impeding this second procedure.

Statistical analysis

The chi-square test and Student’s t-test were used for categorical data and continuous variables, respectively. The Mann-Whitney U Test was used as a non-parametric statistical test. Variables that were considered potentially significant in the bivariate analysis were included in the multivariate analysis. Logistic regression analysis was used to identify the independent risk factors for morbidity and mortality. Results were considered statistically significant if the p-value was ≤ 0.05.

Research ethics

This study has an ethical approval by the hospital’s Research Ethics Committee.

List of abbreviations

  • - Segmental resection with anastomosis (SR)

  • - Total or subtotal colectomy (TC or STC) with digestive anastomosis

  • - Diverting ostomy (DS)

  • - Segmental resection followed by stoma creation (SR-DS)

  • - Total or subtotal colectomy followed by stoma creation (STC-DS)

Results

Sixty-two cases were included in the study. The age distribution of patients in our study ranged from 28 to 100 years, with a median age of 62 years. Almost half of our patients were with no significant medical history (n=29, 45.8%). The most reported co-morbidity was of cardiovascular disease (n=22, 35.5%) (Table 1). The symptom duration was approximately 4,6 days on average. The obstruction’s tetrad was complete in more than half of cases (n=32; 51.6%). Seven of our patients had already diagnosed with a colon cancer (11.3%). The initial diagnosis was made 12,5 weeks after the intestinal obstruction. Upon examination, four patients had dehydration traits. Hemodynamic instability was observed in 3 cases. And three had clinical T4 tumors (Table 2).

Table 1. Demographic characteristics of patients operated on for obstructive colon cancer according to the first-step surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
Gender (number)Male11 (40,7)6 (22,2)02 (7,4)6 (22,2)2 (7,4)0,595
Female12 (34,3)8 (22,9)2 (5,7)3 (8,6)5 (14,3)5 (14,3)
Age in years (standard deviation)62,04 (13,27)60,93 (13,03)67,5 (14,84)56 (21,8)63,27 (16,08)65,29 (18,1)0,907
>= 6511 (39,3)6 (21,4)1 (3,6)2 (7,1)5 (17,9)3 (10,7)0,999
>=756 (46,2)1 (7,7)1 (7,7)1 (7,7)3 (23,1)1 (7,7)0,599
ASA6 score113 (44,8)6 (20,7)02 (6,9)5 (17,2)3 (10,3)0,583
28 (29,6)7 (25,9)1 (3,7)3 (11,1)4 (14,8)4 (14,8)
32 (33,3)1 (16,7)1 (16,7)02 (33,3)0
4000000
>=32 (33,3)1 (16,7)1 (16,7)02 (33,3)00,361
Comorbidities (%)Cardiovascular6 (27,3)6 (27,3)02 (9,1)5 (22,7)3 (13,6)0,597
Renal deficiency00002 (66,7)1 (33,3)0,165
Neurologic deficiency1 (33,3)0002 (66,7)00,373
Respiratory deficiency000000
Endorionological disorders9 (52,9)4 (23,5)1 (5,9)03 (17,6)1 (5,9)0,086
Other tumor6 (60)2 (20)002 (20)0,130
Diabetes7 (43,8)4 (25)1 (6,2)04 (25)00,126
Colo-rectal cancer4 (57,1)1 (14,3)0002 (28,6)0,230

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 American Society of Anesthesiologists score.

Table 2. Clinical data of patients operated on for obstructive colon cancer according to the first-step surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
Abdominal pain (%)Diffuse20 (40)2 (24)1 (2)3 (6)9 (18)5 (10)0,710
Localized3 (27,3)2 (18,2)1 (9,1)2 (18,2)2 (18,2)1 (9,1)
Vomiting (%)No11 (47,8)4 (17,4)005 (21,7)3 (13)0,175
Alimentary7 (30,4)5 (21,7)1 (4,3)5 (21,7)3 (13)2 (8,7)
Bilious5 (35,7)5 (35,7)1 (7,1)02 (14,3)1 (7,1)
Fecaloid00001 (50)1 (50)
Interruption of gaz and stools (%)23 (44,2)10 (19,2)2 (3,8)5 (9,6)7 (13,5)5 (9,6)0,009
Complete occlusive tetrad (%)12 (37,5)7 (21,9)2 (6,2)5 (15,6)4 (12,5)2 (6,2)0,037
Duration (days) (IQR6)4 (4)3 (4,5)42 (10,5)3 (6)4 (4)0,748
Clinically T4 primary tumor (%)2 (66,7)00001 (33,3)0,455
Complicated (%)16 (37,2)7 (16,3)04 (9,3)10 (23,3)6 (14)0,046
Temperature (°c) (IQR)37,2 (0,63)37,1 (0,5)NVNV37 (1,2)370,468
Heart rate (beats per minute) (standard deviation)83,42 (10,06)84,4 (9,26)85 (12,73)82,5 (12,69)83,5 (13,9)94,2 (16,43)0,595
Systolic arterial pressure (standard deviation)128,5 (20,48)123,9 (20,62)115 (21,21)150 (80)124,8 (18,1)113,3 (10,32)0,405
Diastolic arterial pressure (IQR)80 (10)75 (13,75)75 (40)70 (15)65 (30)0,623
Tachycardia (%)1 (16,7)001 (16,7)2 (33,3)2 (33,3)0,193
Hemodynamic instability at admission (%)00001 (50)1 (50)0,389
Spontaneous resolution (%)7 (36,8)10 (52,6)001 (5,3)1 (5,3)0,002

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Interquartile range.

Most of patients had elevated inflammatory markers (n=50, 82%). Anemia was noted in 34 patients (58.6%), while ionic disorders were observed in 26 patients (41.9%) (Table 3).

Table 3. Biological data of patients operated on for obstructive colon cancer according to the first-step surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
CRP (IQR6)9 (63,3)9,7 (30,05)5 (47,3)69,55 (79,1)74,1 (126)0,643
WBC in (standard deviation)9183,2 (3557,2)10367 (2900,7)7710 (438,4)14705 (1623)11506,3 (5837,1)11747,1 (6219,9)<0,000
Elevated inflammatory markers (%)15 (30)14 (28)1 (2)4 (8)11 (22)5 (10)0,111
Hemoglobin in g/dL (std deviation)11,63 (2,40)12,26 (2,23)10,2 (0,14)11,57 (2,32)11,26 (2,75)12,41 (2,61)0,003
Anemia (%)14 (36,8)9 (23,7)2 (5,3)2 (5,3)7 (18,4)4 (10,5)0,882
Platelets count (IQR)320000 (152500)279000 (91250)300000314000278000 (225000)301000 (282000)0,634
Urea (IQR)5,5 (4,14)7,73 (3,89)6,695,5 (8,63)7,3 (4,13)4,78 (9,3)0,634
Hyperurea (%)3 (20)5 (33,3)01 (6,7)4 (26,3)2 (13,3)0,447
Creatinin (IQR)62 (29,07)62 (30,96)58,8380 (38,54)72 (29)67,65 (37,93)0,204
Acute renal injury (%)5 (33,3)4 (26,7)01 (6,7)4 (26,7)1 (6,7)0,760
Ionic disbalance12 (34,3)5 (14,3)1 (2,9)4 (11,4)9 (25,7)4 (11,4)0,216
Natremia (IQR)136 (2)136 (5)133,5135 (6)133 (7)137,5 (7,5)0,198
Hyponatremia (%)4 (21,1)3 (15,8)1 (5,3)2 (10,5)7 (36,8)2 (10,5)0,199
Kalimia (standard deviation)3,6 (1,15)3,5 (1)3,73,2 (0,8)3,5 (1,2)3,2 (0,8)0,473
Hypokalimia (%)9 (37,5)5 (20,8)03 (12,5)4 (16,7)3 (12,5)0,698
Prothrombin time (standard deviation)81,07 (21,27)79,35 (20,89)91,5 (3,56)43 (29,70)82,89 (12,95)87 (7,84)0,465
ACE levels (IQR)4,55 (66,25)3,6 (2,71)NV7NV7,2 (99,98)4,6NV
Elevated ACE7 (53,8)2 (15,4)003 (23,1)1 (7,7)0,381
CA19-9 levels (IQR)14,94 (49,25)13,4 (33,2)NVNV2441,43NV
Elevated CA19-93 (50)1 (16,7)001 (16,7)1 (16,7)0,854
Albumin in (standard deviation)42,96 (7,86)27,63 (4,39)NVNVNVNV0,049
Hypoalbuminea (%)1 (20)3 (60)001 (20)00,382

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Interquartile range.

7 Invalid.

The Left localization was predominant (n=51, 82.3%). On abdominal computed tomography (CT-scan, synchronous tumor) was noted in three patients. Four patients had features of colonic ischemia (pneumoperitoneum, aeroporty, bowel wall hypoenhancement, and submucosal edema). The mean diameter of digestive tract was at 8.3 cm (3.7 – 13). An associated abscess was displaced in five cases. Metastases were observed in 11 patients (18%), with the majority in liver (n=9; 14.5%), followed by peritoneum (n=4; 6.6%) (Table 4). Only two patients had polymetastatic tumors.

Table 4. Radiological data of patients operated on for obstructive colon cancer according to the first-step surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
Tumour widh (mm)16,516 (18)NVNV1716,50,203
Tumor volume (mm)39 (46,75)51,5 (36)33,537,5 (23)50 (39,25)40 (53,5)0,036
Perforated tumour (%)0002 (40)2 (40)1 (20)0,039
Sign of gravity (%)3 (21,4)2 (14,3)03 (21,4)5 (35,7)1 (7,1)0,106
Maximum digestive widh in cm (standard deviation)7,3 (2,02)7,8 (1,54)6,9 (2,68)9,9 (1,71)9,36 (0,86)0,002
Peritoneal effusion (%)No12 (34,3)8 (22,9)02 (5,7)6 (17,1)7 (20)0,145
Little6 (31,6)5 (26,3)2 (10,5)1 (5,3)5 (26,6)0
Moderate3 (50)1 (16,7)02 (33,3)00
Abundant1 (100)00000
Radiological invading1 (25)001 (25)1 (25)1 (25)0,557
Synchronous tumour (%)3 (100)000000,286
Metastasis (%)Metastasis4 (36,4)1 (9,1)1 (9,1)02 (18,2)3 (27,3)0,241
Liver4 (40)01 (10)02 (20)3 (30)0,055
Peritoneum2 (50)1 (25)0001 (25)0,673

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Interquartile range.

7 Invalid.

Based on these findings, patients were operated on accordingly, taking into consideration the presence or absence of clinical, biological, and radiological signs, the tumor site and its number, and the patient’s general well-being. diverting ostomy was the most proposed procedure (n=22; 35.5%), followed by segmental resection (n=15; 24.2%). Subtotal colectomy was the least done procedure (n=2; 3.2%), reserved for synchronous tumor, coecal, or distant ischemic features. Other procedures included Hartmann’s procedure (n=5, 8.1%), segmental resection followed by double ostomy (n=11, 17.7%), and subtotal colectomy followed by ostomy (n=7, 11.3%). There were no demographic differences among the different surgical procedures (Table 1). However, patients who had a diverting ostomy more often had a complete tetrad of intestinal obstruction and had more complications from obstruction (Table 2). Whenever the obstruction ceased spontaneously, the patients were scheduled forsegmental resection, as in elective conditions. As mentioned above, patients who underwentsubtotal colectomy had more intestinal complications; therefore, forthey had the highest incidence of colonic ischemia. If the diameter of the intestinal lumen was large, anastomosis was rejected. STC was also proposed preoperatively in three patients with synchronous tumors (4.81%). Laparotomy was the procedure of choice; laparoscopy was the surgical route in two patients in the second stage of surgery after diverting the ostomy. Intraoperative exploration revealed synchronous tumor in six cases (10.3%). Three synchronous tumors were missed in the radiological assessment. Digestive perforation was observed in nine patients (15.3%). Peritoneal metastases were underdiagnosed on CT, as 15% of patients had carcinomatosis on surgical exploration. Ischemic features were seen in eight patients (13.6%), with pre-perforative coecum being the most reported sign (Table 5).

Table 5. Intra-operative data of patients operated on for obstructive colon cancer according to the first-step surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
Operative timing in days: median (IQR6)NV711 (15,5)11 (2,5)2,5 (1,5)9 (18,25)0,129
Perforated primary tumor (%)2 (22,2)1 (11,1)02 (22,2)3 (33,3)1 (11,1)0,437
Colonic ischemia (%)None18 (40,9)9 (20,5)05 (11,4)10 (22,7)2 (4,5)0,001
Ecchymosis001 (50)001 (50)
Preperforatif Coecum01 (16,7)1 (16,7)004 (66,7)
Peritoneal effusion type (%)Absent18 (40)11 (24,4)2 (4,4)3 (6,7)6 (13,3)5 (11,1)0,265
Serous1 (14,3)3 (42,9)2 (4,4)3 (6,7)6 (13,3)5 (11,1)
Purulent0001 (33,3)2 (28,6)0
Stercoral00001 (50)1 (50)
Peritoneal effusion abundance (%)Little00003 (75)1 (25)0,038
Moderate1 (20)3 (60)01 (20)00
Abundant00002 (66,7)1 (33,3)
Synchronous metastasis (%)4 (66,7)1 (16,7)0001 (16,7)0,311
Locally developing tumor (%)6 (42,9)2 (14,3)01 (7,1)2 (14,3)3 (21,4)0,587
Anesthesia time (min)NV6237,78 (75,63)NV262,5 (63,97)204 (26,07)280 (84,85)0,563
Operative time in minutes (standard deviation)NV204,4 (54,80)NV210 (43,20)176 (35,07)215 (91,92)0,844
Transfusion (%)2 (25)3 (37,5)1 (12,5)02 (25)00,291
Catecholamines (%)3 (42,9)2 (28,6)002 (28,6)00,537

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Invalid.

Postoperative complications occurred in 37.5%, with the majority being surgical; 14 patients (22.6%) developed surgical postoperative complications. Specific surgical complications were the common (n=11; 18%), and they mostly occurring in diverting ostomy patients.

Seven deaths were numbered (11%) (Table 6). Mortality was attributed to 3 hemodynamic instability, acute renal injury with pulmonary edema, anastomotic leakage, pulmonary infection, and peritonitis secondary to tumor perforation after DS.

Table 6. Postoperative data patients operated on for obstructive colon cancer according to the first-stage surgical management.

PDS1SR2STC3HartmannSR with DS4STC with DS5 p
Transfusion (%)3 (23,1)2 (15,4)1 (7,7)1 (7,7)3 (23,1)3 (23,1)0,581
Catecholamines (%)1 (12,5)1 (12,5)01 (12,5)2 (25)3 (37,5)0,230
Global morbidity9 (60)5 (3,33)1 (6,7)0000,005
Surgical morbidity7 (70)3 (30)00000,035
Medical morbidity3 (50)2 (33,3)1 (16,7)0000,195
Specific surgical morbidity5 (45,5)2 (18,2)02 (18,2)02 (18,2)0,213
CD6 III-IV 4 (33,3)3 (25)003 (25)2 (16,7)0,581
Mortality2 (28,6)1 (14,3)002 (28,6)2 (28,6)0,533
Hospital stay (days) (standard deviation)17 (9,39)8 (2,58)10 (4,24)10 (7,73)11 (6,73)15 (7,68)0,130

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Clavien–Dindo score.

In the bivariate analysis, many factors were associated with postoperative mortality, such as neurological morbidity (p = 0.031), history of colorectal cancer (p = 0.005), complete obstructive syndrome (p = 0.043), hemodynamic instability (p=0.011), anemia (p=0.042), elevated CRP (p=0.006), peritoneal metastasis on CT (p=0.045), stercoral peritoneal effusion (p=0.014), per operative catecholamine usage (p=0.002), and postoperative catecholamine usage (p=0.004) (Table 7). On the Linear regression analysis, neurological comorbidity (p=0.027, OR=55%), hemodynamic instability (p≤0.000, OR=63%), peritoneal carcinosis (p<0.000, OR=60%), and catecholamine usage preoperatively (p=0.007, OR=57%) were associated with postoperative mortality. In contrast, anemia (p=0.03), elevated CA19-9 (p=0.016), and peritoneal metastasis on CT (p=0.02) were associated with postoperative morbidity (Table 8). None of the identified determinants of postoperative morbidity were retained in the linear regression.

Table 7. Univariate analysis of associated factors for postoperative mortality after the first-step surgery.

Univariate analysis p
Mortality No mortality
GenderFemale2 (5,7)33 (94,3)0,121
Male5 (18,5)22 (81,5)
Age63620,924
Age >=65 years4 (14,3)24 (85,7)0,390
Age >=75 years2 (15,4)11 (84,6)0,456
Score ASA1 ≥32 (33,3)4 (66,7)0,123
Neurological comorbidity2 (66,7)1 (33,3)0,031
Cardiovascular comorbidity4 (18,2)18 (81,8)0,233
Respiratory comorbidity00NV7
Endocrinological disordors1 (5,9)16 (94,1)0,374
Diabetes2 (12,5)14 (87,5)0,586
Chronic renal disease1 (33,3)2 (86,7)0,306
Colo-rectal cancer3 (42,9)4 (57,1)0,005
Other tumor3 (30)7 (70)0,076
Duration (days)240,357
Complete obstruction syndrome1 (3,1)31 (96,9)0,043
Hear rate (beats per minute)82850,598
Tachycardia06 (100)0,472
Systolic arterial pressure (cmHg)13120,776
Diastolic arterial pressure (cmHg)870,344
Hemodynamic instability2 (100)00,011
Temperature (°c)37,6370,283
Prothrombin time (%)80,5850,675
Platelets count (/mm3)2420003010000,112
Dehydration2 (50)2 (50)0,059
Clinically pT4 tumor1 (33,3)2 (66,7)0,306
Spontaneous resolution3 (15,8)16 (84,2)0,364
Hemoglobin (g/dL)1111,80,400
Anemia7 (18,4)31 (81,6)0,042
Creatinin (μmol/L)61,770,80,111
Acute renal injury1 (6,7)14 (93,3)0,455
Urea (mmol/L)7,56,40,980
Hyper urea2 (13,3)13 (86,7)0,545
C-reactive protein (mg/L)106,912,450,006
Leucocytes8312107920,155
Ionic disbalance6 (17,1)29 (82,9)0,103
Kalimia (IU/L)3,53,50,742
Hypokalimia3 (12,5)21 (87,5)0,558
Natremia (IU/L)1341360,183
Hyponatremia4 (21,1)15 (78,9)0,201
Albuminemia (g/L)32,638,10,487
Hypoalbuminemia1 (20)4 (80)0,462
ACE (μg/L)NVNV
Elevated ACE1 (7,7)12 (92,3)0,544
Ca19-9 (U/mL)NVNV
Elevated CA 19-91 (16,7)5 (89,3)0,528
Tumor siteRight4 (23,5)13 (76,5)0,082
Left3 (6,7)42 (93,3)
Tumor width in mm (IQ2)38,5 (10,5)50 (39)0,194
Associated abscess05 (100)0,585
Locally invading in CT-scan04 (100)0,654
Synchronous tumor in CT-scan03 (100)0,694
Maximum digestive caliber in mm (IQ)88,30,294
Radiological metastasisYes2 (18,2)9 (81,8)
Liver1 (10)9 (90)0,676
Peritoneal2 (50)2 (50)0,045
Complicated obstruction7 (16,3)36 (83,7)0,066
Peritoneal effusion typeAbsent3 (6,7)42 (93,3)0,014
Serous1 (14,3)6 (85,7)
Purulent03 (100)
Stercoral2 (100)0
Peritoneal effusion quantityLittle04 (100)0,097
Moderate1 (20)4 (80)
Abundant2 (66,7)1 (33,3)
Locally invading tumor1 (7,1)13 (92,9)0,560
Digestive perforationYes3 (6,1)46 (93,9)0,040
Diastatic1 (100)0
In situ2 (25)6 (75)
Colonic ischemia1 (12,5)7 (87,5)0,600
Synchronous tumor1 (16,7)5 (83,3)0,497
Peroperative metastasisYes3 (25)9 (75)0,135
Liver03 (100)0,685
Peritoneal3 (33,3)6 (66,7)0,062
Procedure typeSR31 (6,7)14 (93,3)0,527
STC402 (100)
SRDS52 (18,2)9 (81,8)
STCDS62 (28,6)5 (71,4)
Hartmann05 (100)
DS72 (9,1)20 (90,9)
Manual anastomosis1 (8,3)11 (91,7)0,632
Metastasis resetionYes1 (20)4 (80)0,685
Liver01 (100)NV
Peritoneal1 (20)4 (80)0,405
Peroperative catecholamines4 (57,1)3 (42,9)0,002
Preoperative transfusion08 (100)0,346
Anesthesia time (minutes)200220NV
Operative time (minutes)1852120,448
Non extubation on postoperative stay4 (80)1 (20)<0,000
Postoperative transfusion3 (23,1)10 (76,9)0,166
Postoperative catecholamines4 (50)4 (50)0,004
Postoperative antibiotics usage5 (13,2)33 (86,8)0,490
Drainage0 (10,3)35 (89,7)0,495

1 American Society of Anesthesiologists.

2 interquartile range.

3 Segmental resection.

4 Subtotal or total colectomy.

5 Segmental resection with diverting stoma.

6 Subtotal or total colectomy with diverting stoma.

7 Diverting stoma; invalid.

Table 8. Univariate analysis of associated factors for postoperative global morbidity after the first-step surgery.

Univariate analysis p
Morbidity No morbidity
GenderFemale13 (54,2)22 (57,9)0,773
Male11 (45,8)16 (42,1)
Age65610,610
Age >=65 yearsNV8NV
Age >= 75 years13 (54,2)25 (650,360
Score ASA1 ≥ 3NVNV
Neurological comorbidity2 (8,3)1 (2,6)0,554
Cardiovascular comorbidity12 (50)10 (26,3)0,058
Respiratory comorbidity00
Endocrinological disordors7 (29,9)10 (26,3)0,806
Diabetes8 (33,3)8 (21,1)0,282
Chronic renal diseaseNVNV
Colo-rectal cancer2 (8,3)5 (13,2)0,696
Other tumor5 (20,8)5 (13,2)0,490
Complete obstruction syndrome14 (58,3)18 (47,4)0,400
Duration (days)430,782
Temperature (°c)37370,940
Tachycardia4 (16,7)12 (31,6)0,242
Heart rate (beats per minute)8481NV
Hemodynamic instability02 (5,3)0,518
Systolic arterial pressure (cmHg)13120,046
Diastolic arterial pressure (cmHg)870,134
Clinically pT4 tumor03 (7,9)0,277
Spontaneous resolution8 (33,3)11 (28,9)0,715
Prothrombin time (%)84860,304
Anemia17 (77,3)17 (47,2)0,030
Platelets count (/mm3)2770003020000,492
Hemoglobin (g/dL)1112,20,068
Acute renal injury2 (8,3)6 (15,8)0,468
Creatinin (μmol/L)6267,50,602
Hyper urea12 (50)14 (36,8)0,306
Urea (mmol/L)7,66,40,709
Ionic disbalance12 (50)14 (36,8)0,306
Elevated inflammatory markers21 (91,3)29 (76,3)0,182
Hypokalimia15 (62,5)15 (39,5)0,077
Kalimia (IU/L)3,23,50,142
Hyponatremia8 (33,3)15 (39,5)0,626
Natremia (IU/L)1361360,454
HypoalbuminemiaNVNV
Albuminemia (g/L)32400,130
Elevated ACE15 (62,5)29 (76,3)0,243
ACE (μg/L)4,14,90,787
Elevated CA 19-919 (79,2)27 (71,1)0,477
Ca 19-9 (U/mL)36110,016
Tumor siteRight5 (20,8)12 (31,6)0,356
Left19 (79,2)26 (68,4)
Tumor width in mm (IQ2)44460,755
Associated abscess2 (8,3)3 (8,1)1
Locally invading in CT-scan1 (4,2)3 (8,1)1
Synchronous tumor in CT-scanNVNV
Maximum digestive caliber in mm (IQ)8,68NV
Radiological metastasisLiver5 (20,8)5 (13,5)0,495
Peritoneal4 (16,7)00,020
Complicated obstruction17 (70,8)26 (68,4)0,841
Peritoneal effusion typeAbsent19 (90,5)26 (72,2)0,138
Serous1 (4,8)6 (16,7)
Purulent1 (4,8)2 (5,6)
Stercoral02 (5,6)
Locally invading tumor3 (13,6)11 (29,7)0,160
Digestive perforationYes2 (9,1)7 (19,5)0,345
Diastatic01 (2,8)
In situ2 (9,1)6 (16,7)
Colonic ischemia2 (10)6 (18,7)0,550
Synchronous tumor1 (4,5)5 (13,9)0,392
Procedure typeSR35 (20,8)10 (26,3)0,525
STC41 (4,2)1 (2,6)
SRDS53 (12,5)8 (21,1)
STCDS63 (12,5)4 (10,4)
Hartmann3 (12,5)2 (5,3)
DS79 (37,5)13 (34,2)
Manual anastomosis3 (25)9 (47,4)0,274
Metastasis resectionLiver03 (8,1)0,279
Peritoneal5 (21,7)4 (10,8)0,284
Peroperative catecholamines3 (12,5)4 (11,1)1
Preoperative transfusion2 (8,3)6 (16,7)0,457
Anesthesia time (minutes)2452100,095
Operation time (minutes)2202000,443
Non extubation on postoperative period1 (4,2)4 (11,1)0,639
Postoperative transfusion7 (29,2)6 (16,7)0,250
Postoperative catecholamines3 (12,5)5 (13,9)1
Drainage14 (58,3)25 (67,6)0,463

1 American Society of Anesthesiologists.

2 Interquartile range.

3 Segmental resection.

4 Subtotal or total colectomy.

5 Segmental resection with diverting stoma.

6 Subtotal or total colectomy with diverting stoma.

7 Diverting stoma.

8 Invalid.

Concerning specific surgical complications, the only statistically significant factors in the bivariate analysis were delayed consulting time (5 vs. 3 days, p=0.037), elevated CA 19-9 levels (p=0.021), peritoneal carcinomatosis on CT scan (p=0.02) or during surgical exploration (p=0.013), and longer anesthetic time (315 vs. 210 min, p=0.008) (Table 9). However, these factors were not confirmed in multivariate analysis (Table 10).

Table 9. Univariate analysis of associated factors for postoperative specific morbidity after the first-step surgery.

Univariate analysis p
Specific surgical complications No morbidity
GenderFemale7 (20)28 (80)0,745
Male4 (15,4)22 (84,6)
Age58630,427
Age >=65 yearsNV8NV
Age >= 75 years7 (18,9)30 (81,1)1
Score ASA1 ≥ 3NVNV
Neurological comorbidity03 (100)1
Cardiovascular comorbidity4 (18,2)18 (81,8)1
Respiratory comorbidity00
Endocrinological disordors2 (11,8)15 (88,2)0,712
Diabetes2 (12,5)14 (87,5)0,711
Chronic renal diseaseNVNV
Colo-rectal cancer2 (28,6)5 (71,4)0,599
Other tumor3 (30)7 (70)0,367
Complete obstruction syndrome7 (21,9)25 (78,1)0,412
Duration (days)530,037
Temperature (°c)3737,10,725
Tachycardia2 (12,5)14 (87,5)0,711
Heart beat (beats per minute)82840,360
Hemodynamic instability02 (100)1
Systolic arterial pressure (cmHg)1201200,620
Diastolic arterial pressure (cmHg)80700,080
Dehydration2 (50)2 (50)0,150
Clinically pT4 tumor1 (33,3)2 (66,7)0,455
Spontaneous resolution8 (33,3)11 (28,9)0,715
Prothrombin time (%)76860,092
Anemia7 (20,6)27 (79,4)1
Platelets count (/mm3)3140002940000,564
Hemoglobin (g/dL)11,611,70,868
Acute kidney injury2 (25)6 (75)0,627
Creatinin (μmol/L)80630,592
Hyper urea5 (19,2)21 (80,8)1
Urea (mmol/L)6,36,70,754
Ionic disbalance7 (26,9)19 (73,1)0,179
Elevated inflammatory markers10 (20,4)39 (79,6)0,670
Leucocytes (/mm3)11495103880,446
C-reactive protein (mg/L)20,218,2NV
Hypokalimia15 (62,5)23 (76,7)0,077
Kalimia (IU/L)3,23,50,225
Hyponatremia3 (13,6)19 (86,4)0,731
Natremia (IU/L)1351360,382
Albuminemia (g/L)32400,130
Elevated ACE8 (18,6)35 (81,4)1
ACE (μg/L)4,34,60,795
Elevated CA 19-99 (20)36 (80)0,711
Ca 19-9 (U/mL)58,6120,021
Tumor siteRight2 (11,8)15 (88,2)0,712
Left9 (20,5)35 (79,5)
Tumor width in mm (IQ2)50450,803
Associated abscess1 (20)4 (80)1
Locally invading in CT-scan04 (100)1
Synchronous tumor in CT-scan03 (100)1
Maximum digestive caliber in mm (IQR)8,58NV
Radiological metastasisLiver5 (20,8)5 (13,5)0,495
Peritoneal4 (16,7)00,020
Complicated obstruction17 (70,8)26 (68,4)0,841
Peritoneal effusion typeAbsent10 (22,7)34 (77,3)0,112
Serous07 (100)
Purulent03 (100)
Stercoral02 (100)
Locally invading tumor2 (14,3)12 (85,7)1
Digestive perforationDiastatic02 (25)0,616
In situ2 (25)6 (75)
Colonic ischemia1 (12,5)7 (87,5)1
Synchronous tumor2 (33,3)4 (66,7)0,281
Peroperative metastasisYes
Liver3 (33,3)6 (66,7)0,163
Peritoneal3 (75)1 (25)0,013
Procedure typeSR35 (20,8)10 (26,3)0,525
STC41 (4,2)1 (2,6)
SRDS53 (12,5)8 (21,1)
STCDS63 (12,5)4 (10,4)
Hartmann3 (12,5)2 (5,3)
DS79 (37,5)13 (34,2)
Manual anastomosis1 (8,3)11 (91,7)0,624
Peroperative catecholamines1 (14,3)6 (85,7)1
Preoperative transfusion2 (8,3)7 (87,5)0,457
Anesthesia time (minutes)3152100,008
Operation time (minutes)2531970,060
Non extubation on postoperative period2 (40)3 (60)0,230
Postoperative transfusion3 (23,1)10 (76,9)0,693
Postoperative catecholamines2 (25)6 (75)0,635
Drainage6 (15,8)32 (84,2)0,511

1 American Society of Anesthesiologists.

2 Interquartile range.

3 Segmental resection.

4 Subtotal or total colectomy.

5 Segmental resection with diverting stoma.

6 Subtotal or total colectomy with diverting stoma.

7 Diverting stoma.

8 Invalid.

Table 10. Multivariate analysis of our cohorte.

FactorOdd ratio95% IC p
MortalityNeurological comorbidity0.550.0.36-0.5790.027
Hemodynamic instability0.630.409-1.1570.000
Peritoneal metastasis0.60.306-0.7540.000
Peroperative catecholamines0.570.097-0.5540.007

The second stage surgery was performed in only 21 patients from 42 patients (50%), Hartmann’s reversal in 1 patient only from 5 patients (20%), stoma closure following SR-DS or STC-DS in 5 patients from 19 patients (26.3%), and resection following diverting ostomy in 15 cases from 18 patients. Among patients not undergo the second surgical procedure (21, 50%), 11 patients were lost to follow-up after the first surgical procedure, seven patients were referred for palliative care due to polymetastatic disease (5 patients developed diffuse peritoneal carcinosis on postoperative CT, and 2 patients had multiple metastases from the preoperative period), three patients died following the first surgical procedure.

There was no statistical difference between the different surgical procedures when analyzing the postoperative morbidity or mortality in second-stage surgery (Table 11). Table 12 showcases cumulative postoperative morbidity and mortality after first and second surgeries.

Table 11. Postoperative data patients operated on for obstructive colon cancer according to the second-stage surgical management.

Hartmann reversalStoma takedownResection following PDS2 p
Feasibility, done (%)1 (4,8)5 (23,8)15 (71,4)<0,000
Global morbidity02 (66,7)1 (33,3)0,207
Surgical morbidity001 (100)0,629
Medical morbidity01 (100)00,258
Specific surgical morbidity001 (100)0,491
CD1 III-IV 001 (100)0,491
Mortality000

1 Clavien Dindo score;

2 Proximal diverting stoma.

Table 12. Cumulative postoperative results.

DS1SR2STC3HartmannSR with DS4STC with DS5 p
Global morbidity5 (33,3)11 (45,8)1 (50)3 (60)5 (45,5)5 (71,4)0,591
Medical morbidity4 (19)3 (20)1 (50)03 (27,3)3 (42,9)0,412
Surgical morbidity5 (23,8)3 (20)03 (60)1 (9,1)2 (28,6)0,381
Specific surgical morbidity5 (23,8)2 (13,3)02 (40)1 (28,6)1 (11,1)0,231
CD6 III-IV 5 (22,7)3 (20)003 (27,3)2 (28,6)0,576
Mortality2 (9,5)1 (6,7)002 (18,2)1 (28,6)0,534

1 Proximal diverting stoma.

2 Segmental resection.

3 Subtotal or total colectomy.

4 Segmental resection with diverting stoma.

5 Subtotal or total colectomy with diverting stoma.

6 Clavien-Dindo complications classified as III or IV.

Discussion

Intestinal obstructions are frequent and dreadful. Colonic tumors are the leading cause of death in developed countries. Its treatment is controversial because of the plethora of available procedures. An adequate assessment of the patient’s status and the results of each procedure will help in the choice of therapeutic measures. Our study provides a detailed treatment path for patients with obstructive colon tumors, with emphasis on the current treatment landscape. Postoperative complications occurred in 37.5% with the majority being surgical (n=14, 22.6%). Seven deaths were numbered (11%). Neurological comorbidity (p=0.027, OR=55%), hemodynamic instability (p≤0.000, OR=63%), peritoneal carcinosis (p<0.000, OR=60%), and catecholamine usage peroperatively (p=0.007, OR=57%) were associated with postoperative mortality.

According to the World Cancer Research Fund, colorectal cancer (CRC) is the third most common cancer worldwide, regardless of sex, with 1.9 million new cases in 2020.15 In women, it is the second most common cancer, while in men, it is the third most common.15 On a smaller scale, the American Cancer Society estimated 106970 new cases of CRC in the United States.16 It is also the second leading cause of cancer-related deaths, with an estimated 52550 deaths by 2023.16

In Tunisia, a recent publication by the Global Cancer Observatory highlighted that colorectal cancer ranks 5th among newly diagnosed cancer cases, representing 9.6% of 988 new cases in 2020, and is the 5th leading cause of death, representing 4.6% of 542 deaths in 2020.17 A retrospective study, conducted between 1994 and 2009, and including patients registered in Tunisia’s northern cancer registry, with the aim of predicting regional colorectal cancer incidence in 2024, showed that there is an upward trend in cumulative risk estimated at + 3.9% [2.8% - 5.1%].18 Without screening, the age-standardized rate will reach 39.3/100,000 for men and 22.9/100,000 for women in 2024, that is double the figure announced at the end of the data collection.18

In literature reviews, bowel obstruction is the revealing manifestation of 8 to 40% of colonic tumors.1921 Moreover, occlusive syndrome is the most frequent emergency during the course of colonic cancers, accounting for 75% to 85% of cases.1,2,22,23

The postoperative morbidity and mortality of colonic tumors in occlusion are higher than those in elective surgery, regardless of the type of surgery performed.24 Mortality is observed in 9% of patients operated surgery for a colonic tumor obstruction, and the occurrence of postoperative complications affects half of all patients operated on, as shown by the French Association of Surgery.25 This rate is threefold that of elective surgery for colonic tumors.26

Intestinal obstruction impairs oncological prognosis and is responsible for a decline in 5-year-cancer-specific-survival from 70.9% to 52.9%.27 For this reason, the National Cancer Control Network (2014) and the European Society for Medical Oncology (2012) consider occlusion, complicating colonic tumors, to be a poor prognostic factor in the development of adjuvant treatment modalities.28,29

Therefore, a better understanding of the determinants of postoperative complications can improve therapeutic management and prognosis.

A total of 62 patients were included in the study, representing a heterogeneous series, including right and left localization, of colon cancer cases presenting with intestinal obstruction. Notably, we observed a wide range of surgical procedures in our study population, reflecting the diversity of patients with colon cancer requiring surgical intervention. Their ages ranged from 28 to 100 years old. Among these, 72.6% had left sided colon cancer and the remaining 27.4% were diagnosed with right sided colon cancer. This result is in accordance with those of other authors,3033 where distal tumors exhibitedobstructive behavior. This distribution underscores the varied sieges of obstructive colon malignancies encountered in clinical practice and emphasizes the importance of considering different therapeutic plans. Among our patients, 13.6% had ischemic features when operated upon. This high proportion was similarly observed (12%) by a Japanese team.31 Guo M Gao et al. noted a high incidence of peritonitis (19.7%) and colonic perforation (9%) in patients exceeding 70 years old.34 Our study investigated patients admitted for colonic tumoral obstruction with an emphasis on their surgical outcometo define the factors associatedwith morbidity and mortality. We noted that postoperative complications occurred in a third of our patients (37.5%) and were essentially of surgical nature (22.6% of our patients). This incidence is similar to Shunji Morita et al. results (34%)31 but lower than what was observed in a large cohort of French Association of Surgery, which scored 51% of global morbidity.35 In older patients, complications occur more frequently as highlighted by Guo M Gao et al. (62.2%).34 With regard to the nature of postoperative complications, our results were lower than those observed by Bouare et al.36 The highest proportion of surgical complications occurred in a large cohort study by the French Association of Surgery (90%).35 Whereas ower rates (11,9%) were reported by Ker Kan Tan et al.30

In our series, postoperative complications led to 11% of mortality, comparable to what was observed by Ker Kan Tan et al. (11.9%).30 A lower mortality rate was reportedin a Dutch series (6.9%),37 and higher rates were observed in senile patients, where 24.5% of patients died, as reported by Ming Gao Guo.34 The selection of these at-risk patients to develop postoperative complications would lead to better perioperative management.

Few studies have focused on determining factors associatedwith postoperative morbidity. Therefore, our study contributes to enriching the present data. In fact, diabetes mellitus is another factor to be considered, as it increases the occurrence of postoperative complications (p=0.004) and redo surgery (p=0.01) and is associated with longer stay in intensive care units (p=0.02).38 Our univariate analysis linked a longer anesthetic time to the occurrence of specific surgical complications (315 vs. 210 min, p=0.008). Our result is consistent with a retrospective Romanian series involving 449 patients, published in 2022, and concluded that a threshold value for operating time exceeding 2 h 30 minwas associated with additional morbidity (p < 0.05) and an area under the curve of 0.83.39 However, mastering the anesthesia time did not reduce postoperative mortality. A large multicenter French series 1983 patients retrospectively showed that operating time does not influence postoperative mortality, even if the operating time lasts more than 150 min (p=0.46).40

There is a dearth of data regarding the risk factors for postoperative mortality in patients with obstructive colon tumors. Our study adds to the existing literature on postoperative mortality and underscores the importance of individualized surgical planning strategies based on accurate preoperative and peroperative assessments of patients. In fact, when considering that neurological comorbidity (p=0.027, OR=55%), hemodynamic instability (p≤0.000, OR=63%), peritoneal carcinosis (p<0.000, OR=60%), and catecholamine usage preoperatively (p=0.007, OR=57%) were associated with postoperative mortality, surgeons could modify their approach accordingly to minimize surgery’s impact and ramp up postoperative surveillance to detect subtle complications. Our results are consistent with those ofot previous studies. Patients with left obstructive colon tumorswho had neurological comorbidities were found to be prone to postoperative mortality (p=0.049; OR=1.89).41 The same study linked pulmonary comorbidities to postoperative mortality (p=0.04; OR=2).41 Coronary insufficiency (p=0.001; OR=5.83) and chronic renal disease (p<0.001; OR=23.54) negatively influenced the postoperative course in a prospective Egyptian study.42 To our knowledge, our results showing peritoneal carcinosis as an associated factor for postoperative mortality is the first to highlight such a finding. Mroua et al. found this interrelation only in their univariate analysis.43 However, in 2018, the French Surgical Association did not confirm this statistical association in their report of 1220 patients operated surgery for left colonic tumors in occlusion (p=0.3).41 However, local studies do not share our findings. The Tunisian Surgical Association, analyzing 635 patients who underwent surgery for a left colonic tumor in occlusion at 21 hospital centers between 2003 and 2013, showed that intraoperative presence of peritoneal carcinosis did not increase mortality or specific surgical morbidity (p=1 and p=0.11, respectively).44

Limitations: It is noteworthy that our study had some limitations, including its retrospective nature and small sample size. While our broad inclusion allowed for a comprehensive assessment of the course of patients with obstructive colonic tumors, it also contained heterogeneity in the study population. As different surgical procedures may exhibit variations in the postoperative course, the generalizability of our findings to patients with colon cancer with intestinal obstruction may be influenced by this heterogeneity.

Conclusion

Colonic cancers are among the most deadliest neoplasms. This can be explained by dreadful complications. Intestinal obstruction was the most frequently reported complication. This presents a therapeutic dilemma because of the multiplicity of procedures and frail patients. Treatment should be tailored to the patient’s medical history and repercussions of the affection to avoid the occurrence of postoperative complications. We determined that neurological comorbidity, hemodynamic instability, peritoneal carcinosis, and catecholamine use preoperativelywere associated with postoperative mortality. Although factors associated with postoperative morbidity were not determined in our study, we encourage further studies to resolve this question. Considering these factors, surgeons can identify high-risk patients, strengthen preoperative preparations, adjust surgical strategies and techniques, detect potential complications early, and intervene in a timely manner.

Declarations

Ethics approval and consent to participate

This study did not require ethical approval owing to its retrospective nature. Moreover, it did not include identifiable patient information, and the studies analyzed data that were already collected.

Consent for participation and publication

Patients’ consent was obtained for participation and publication.

Clinical trial number

Not applicable.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 05 Sep 2025
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Mohamed Ali M, Rakia S, Chaima Y et al. Associated factors for postoperative morbidity and mortality following surgery of obstructive colon tumors [version 1; peer review: awaiting peer review]. F1000Research 2025, 14:875 (https://doi.org/10.12688/f1000research.168143.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status:
AWAITING PEER REVIEW
AWAITING PEER REVIEW
?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 05 Sep 2025
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.